Home  /  Resource Library  /  Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richters transformation

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richters transformation

Study examined ibrutinib combined with nivolumab for treatment of relapsed DLBCL, follicular lymphoma and Richter’s Transformation.